Mostrar el registro sencillo del ítem

Autordc.contributor.authorTorres Mendoza, Cristian 
Autordc.contributor.authorIturriaga, María P. 
Autordc.contributor.authorCruz, Pamela 
Fecha ingresodc.date.accessioned2021-09-20T14:00:18Z
Fecha disponibledc.date.available2021-09-20T14:00:18Z
Fecha de publicacióndc.date.issued2021
Cita de ítemdc.identifier.citationAnimals 2021, 11, 608es_ES
Identificadordc.identifier.other10.3390/ani11030608
Identificadordc.identifier.urihttps://repositorio.uchile.cl/handle/2250/181979
Resumendc.description.abstractCanine mammary cancer corresponds to a tumor disease that frequently affects female dogs, especially those that are reproductively intact. This disease can decrease the survival and quality of life of affected animals; therefore, it is important to know the underlying mechanisms. Hormonal factors are very important for the development of this pathology. Estradiol, a hormone produced primarily in the ovaries actively participates in the process of mammary tumor formation, but the principal mechanisms behind this carcinogenic role remain incompletely understood. This review will discuss how estradiol would induce its pro-tumor effect on the mammary tissue, thus contributing to the understanding of the mechanisms involved in the development of this disease. Mammary cancer is a frequent neoplasia in female dogs, in which most important risk factors are hormonal. Sexual hormones as estradiol play an important role in mammary carcinogenesis, being able to induce carcinogenic initiation, promotion and progression. However, the molecular mechanisms involved are incompletely understood. Estradiol is synthesized mainly in the ovaries, nevertheless, high concentrations of estradiol and some of its hormonal precursors have also been described in malignant mammary tumor tissue. The mechanisms of action of estradiol include the classic genomic effects that modulate gene transcription, and non-genomic effects, which trigger quick effects after estradiol binds to its specific receptors. These responses modulate various intracellular signaling pathways, triggering post-translational modification of several proteins. This review will discuss the well-known underlying mechanisms associated with the action of estradiol in the malignant progression of canine mammary tumors.es_ES
Patrocinadordc.description.sponsorshipComision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) CONICYT FONDECYT 1201441es_ES
Idiomadc.language.isoenes_ES
Publicadordc.publisherMDPIes_ES
Tipo de licenciadc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link a Licenciadc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Fuentedc.sourceAnimalses_ES
Palabras clavesdc.subjectHormonal carcinogenesises_ES
Palabras clavesdc.subjectCanine mammary canceres_ES
Palabras clavesdc.subjectEstradioles_ES
Palabras clavesdc.subjectTumor progressiones_ES
Títulodc.titleHormonal Carcinogenesis in Canine Mammary Cancer: Molecular Mechanisms of Estradiol Involved in Malignant Progressiones_ES
Tipo de documentodc.typeArtículo de revista
Catalogadoruchile.catalogadorcrbes_ES
Indizaciónuchile.indexArtículo de publicación ISIes_ES


Descargar archivo

Icon

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 3.0 Chile
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 3.0 Chile